BiolineRx Jumps Most on Record After Deal With Genoscience

BioLineRx Ltd. surged the most on record after the Israeli company that develops therapeutic pharmaceutical drugs signed a deal with France’s Genoscience to develop and commercialize a treatment.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.